Novel monoclonal antibody can substantially lower triglycerides in patients with acute pancreatitis
The investigational drug evinacumab reduced triglycerides in patients with severe hypertriglyceridemia (sHTG) and a history of hospitalizations for acute pancreatitis in a phase 2 global study led by Mount Sinai. The fully ...
May 16, 2021
0
3